Background: Fragile X mental retardation syndrome (FXS) is the most common familial cause of intellectual disability and the most common known cause of autism. Other symptoms of FXS include depression, sensory processing deficits, aggressive behavior, connective tissue problems and digestive difficulties. This disorder arises when the number of CGG-repeats in the 5 UTR of the FMR1 gene exceeds 200. Such alleles become silenced. This results in a deficiency of the protein product of this gene, FMRP, which is involved in the regulation of translation of a subset of mRNAs. The FMRP deficiency in brain results in aberrant dendritic spine morphology and a defective response to synaptic activation. The mechanism of gene silencing is unknown. Progress report: We have previously identified a late event in the silencing process and shown that reversal of this event enables gene reactivation (Biacsi, Kumari and Usdin, 2008). In the past year we have been focusing on events that occur earlier in the silencing process. We have shown that in addition to histone H3 dimethylated at lysine 9 (H3K9Me2) and trimethylated at lysine 27 (H3K27Me3), silenced alleles are associated with elevated levels of histone H3 trimethylated at lysine 9 (H3K9Me3) and histone H4 trimethylated at lysine 20 (H4K20Me3). All four of these modified histones are present on exon 1 of silenced alleles at levels comparable to that seen on pericentric heterochromatin. H3K9Me2 and H3K27Me3 have a broad distribution across the 5'end of the gene, and may arise from spreading from an upstream heterochromatic zone we have identified 5'of the FMR1 gene. In contrast, H3K9Me3 and H4K20Me3 have a more focal distribution with the highest level of these marks being present in the vicinity of the repeat. This distribution provides clues as to the mechanism of gene silencing and suggests that the trigger for this silencing may be local to the repeat itself and may involve a mechanism similar to that involved in the formation of pericentric heterochromatin.

Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2010
Total Cost
$323,483
Indirect Cost
City
State
Country
Zip Code
Hayward, Bruce E; Usdin, Karen (2017) Improved Assays for AGG Interruptions in Fragile X Premutation Carriers. J Mol Diagn 19:828-835
Hayward, Bruce E; Kumari, Daman; Usdin, Karen (2017) Recent advances in assays for the fragile X-related disorders. Hum Genet 136:1313-1327
Hayward, Bruce E; Zhou, Yifan; Kumari, Daman et al. (2016) A Set of Assays for the Comprehensive Analysis of FMR1 Alleles in the Fragile X-Related Disorders. J Mol Diagn 18:762-774
Conca Dioguardi, Carola; Uslu, Bahar; Haynes, Monique et al. (2016) Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency. Mol Hum Reprod 22:384-96
Kumari, Daman; Usdin, Karen (2016) Sustained expression of FMR1 mRNA from reactivated fragile X syndrome alleles after treatment with small molecules that prevent trimethylation of H3K27. Hum Mol Genet 25:3689-3698
Zhou, Yifan; Kumari, Daman; Sciascia, Nicholas et al. (2016) CGG-repeat dynamics and FMR1 gene silencing in fragile X syndrome stem cells and stem cell-derived neurons. Mol Autism 7:42
Kumari, Daman; Swaroop, Manju; Southall, Noel et al. (2015) High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells. Stem Cells Transl Med 4:800-8
Usdin, Karen; Kumari, Daman (2015) Repeat-mediated epigenetic dysregulation of the FMR1 gene in the fragile X-related disorders. Front Genet 6:192
Kumari, Daman; Usdin, Karen (2014) Polycomb group complexes are recruited to reactivated FMR1 alleles in Fragile X syndrome in response to FMR1 transcription. Hum Mol Genet 23:6575-83
Kumari, Daman; Bhattacharya, Aditi; Nadel, Jeffrey et al. (2014) Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs. Hum Mutat 35:1485-94

Showing the most recent 10 out of 17 publications